| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Dec 8, 25 | Finch Norman D. Jr. | Grant | - | |
| Dec 8, 25 | Finch Norman D. Jr. | Grant | $124K | |
| Sep 30, 25 | HAUGEN JANET BRUTSCHEA | Grant | $13K | |
| Aug 11, 25 | McMahon Robert W. | Grant | - | |
| Aug 11, 25 | McMahon Robert W. | Grant | - | |
| Aug 11, 25 | McMahon Robert W. | Grant | $1.8M | |
| Aug 11, 25 | McMahon Robert W. | Grant | $1.7M | |
| Jun 30, 25 | HAUGEN JANET BRUTSCHEA | Grant | $13K | |
| May 12, 25 | Campbell Shane Alden | Grant | - | |
| May 12, 25 | Campbell Shane Alden | Grant | - |
WEST PHARMACEUTICAL SERVICES INC ((WST)) has recorded 2 640 insider transactions from 58 insiders. Total insider buying volume stands at $1.5M, while total selling volume is $287.3M. Overall insider sentiment is bearish (97% sales).
WEST PHARMACEUTICAL SERVICES INC ((WST)) has recorded 2 640 insider operations, including 12 open-market purchases ($1.5M), 374 sales ($287.3M) and 2 254 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (97% sales).
Insider activity at WEST PHARMACEUTICAL SERVICES INC is sustained, with operations recorded in 8 of the last 12 months — a sign of regular regulatory filings.
Among the most active insiders are MOREL DONALD E JR (CEO), Green Eric Mark (CEO) & FEDERICI WILLIAM J (CFO), with respectively 350, 242, 211 transactions.
Across all 2 640 recorded transactions, the breakdown by type is: grant (1520, 58%), exercise (499, 19%), sells (374, 14%), tax (144, 5%), gift (72, 3%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
WEST PHARMACEUTICAL SERVICES INC has recorded 2 640 insider operations in total, including 12 open-market purchases ($1.5M), 374 sales ($287.3M) and 2 254 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on December 8, 2025.
Insiders at WEST PHARMACEUTICAL SERVICES INC are currently net sellers, with 3% purchases and 97% sales across all reported transactions. Total buy volume is $1.5M versus $287.3M in sales, indicating a bearish insider sentiment.
InsiderLens tracks 58 insiders at WEST PHARMACEUTICAL SERVICES INC ((WST)). MOREL DONALD E JR (CEO, 350 tx), Green Eric Mark (CEO, 242 tx), FEDERICI WILLIAM J (CFO, 211 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for (WST) is bearish, based on a 3% buy ratio across 386 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for WEST PHARMACEUTICAL SERVICES INC comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.